NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2647-2654

  Yamaura, Maki ^a   Mitsushita, Junji ^a   Furuta, Shuichi ^a   Kiniwa, Yukiko ^a   Ashida, Atsuko ^a   Goto, Yasuhumi ^a   Shang, Wei H ^a   Kubodera, Makoto ^a   Kato, Masayoshi ^a   Takata, Minoru ^a   Saida, Toshiaki ^a   Kamata, Tohru ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CYCLIN DEPENDENT KINASE 1; DIPHENYLIODONIUM SALT; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; SUPEROXIDE; ANTIOXIDANT; CDC25C PROTEIN, HUMAN; NOX4 PROTEIN, HUMAN; PROTEIN TYROSINE PHOSPHATASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; AGED; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL TRANSFORMATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION; AMINO ACID SEQUENCE; BIOSYNTHESIS; CELL DIVISION; CELL GROWTH; DRUG ANTAGONISM; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANTIOXIDANTS; CDC2 PROTEIN KINASE; CDC25 PHOSPHATASES; CELL DIVISION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; G2 PHASE; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; NADPH OXIDASE; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION;

EID: 65549114660     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3745     Document Type: Article

References (30)

1. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4:181-9.
2. Lassegue B, Sorescu D, Szoes K, et al. Novel gp91(phox) homologues in vascular smooth muscle cells: noxl mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001;88:888-94.
3. Suh YA, Arnold RS, Lassegue R, et al. Cell transformation by the superoxide-generatlng oxidase Moxl. Nature 1999;401:79-82.
4. Mitsushita J, Lambeth JD, Kamata T. The superoxide- generating oxidase Noxl is functionally required for Ras oncogene transformation. Cancer Res 2004;64:3580-5.
5. Pedruzzi E, Guiehard C, Ollivier et al. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol 2004;24:10703-17.
6. Park HS, Jung HY, Park EY. Kim J, Lee WT, Bae YS. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 Isozyme is essential for lipopolysaccharide- induced production of reactive oxygen species and activation of NF-κB. J Immunol 2004;173:3589-93.
7. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991;51:794-8.
8. Shinohara M, Shang WH, Kubodera M, et al. Noxl redox signaling mediates oncogenic Ras-lnduced disruption of stress fibers and focal adhesions by down- regulating Rho. J Biol Chem 2007;282:17640-8.
9. Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I, Gukovskaya AS. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 2004;279:34643-54.
10. Mochizuki T, Furuta S, Mitsushita J, et al. Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene 2006;25:3699-707.
11. Brar SS, Corbin Z, Kennedy TP, et al, NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol Cell Physiol 2003;285: C353-69.
12. Fu X, Beer DG, Behar J, Wands J, Lambeth D, Cao W. cAMP-response element-binding protein mediates acid- induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J Biol Chem 2006;281: 20368-82.
13. Sander CS, Hamm F, Eisner P, Thiele JJ, Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br J Dermatol 2003;148:913-22.
14. Church SL, Grant JW, Ridnour LA, et al. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A 1993;90:3113-7.
15. Prasad KN, Edwards-Prasad J. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res 1982;42:550-5.
16. Valencia A, Kochevar IE. Noxl-based NADPH oxidase is the major source of UVA-induced reactive oxygen species in human keratinocytes. J Invest Dermatol 2008; 128:214-22.
17. Brar SS( Kennedy TP, Sturrock AB, et al. An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol 2002;282;C1212-24.
18. Byers HR, Etoh T, DohertyJR, Sober AJ, Mihm MC, Jr. Cell migration and actin organization in cultured human primary', recurrent cutaneous and metastatic melanoma Time-lapse and image analysis. Am J Pathol 1991;139:423-35.
19. Lee MS, Ogg S, Xu M, et al. cdc25+ encodes a protein phosphatase that dephosphorylates p34cdc2. Mol Biol Cell 1992;3:73-84.
20. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75: 805-16.
21. Xiong Y, Harmon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-4.
22. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997;277:1501-5.
23. Herman-Antosiewicz A, Singh SV. Checkpoint kinase 1 regulates diallyl trisulfide-induced mitotic arrest in human prostate cancer cells, J Biol Chem 2005;280: 28519-28.
24. Kumagai A, Dunphy WG. Binding of 14-3-3 proteins and nuclear export, control the intracellular localization of the mitotic inducer Cdc25. Genes Dev 1999;13: 1067-72.
25. Xiao D, Herman-Antosiewicz A, Antosiewicz j, et al. Diallyl trisulfide-induced G(2)-M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphos- phorylation of Cdc 25 C. Oncogene 2005;24:6256-68.
26. Geiszt M, Kopp JB, Varnai P, Leto TL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 2000;97:8010-4.
27. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
28. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma N Engl J Med 2005; 353:2135-47.
29. Takata M, Saida T. Genetic alterations in melanocyte tumors, J Dermatol Sci 2006;43:1-10.
30. Murakami S, Noguchi T, Takeda K, Ichijo H. Stress signaling in cancer. Cancer Sci 2007;98:1521-7.